Tuberculosis and HIV co-infection: do we have a surveillance system in Europe? Source: Eur Respir J 2011; 38: 1258-1260 Year: 2011
Control of MDR-/XDR-TB and elimination of TB in Europe: status update Source: Annual Congress 2012 - Fighting MDR- and XDR-TB in Europe: from programme results to research implementation Year: 2012
HIV testing in new patients with TB: attitudes and action in the U.K. in 2006 Source: Annual Congress 2007 - Tuberculosis control Year: 2007
The burden of TB–HIV in the EU: how much do we know? A survey of surveillance practices and results Source: Eur Respir J 2011; 38: 1374-1381 Year: 2011
Tuberculosis patients with unknown HIV status in the Netherlands: analysing underreporting and lack of testing Source: Eur Respir J, 50 (5) 1701257; 10.1183/13993003.01257-2017 Year: 2017
Trilateral overlap of tuberculosis, diabetes and HIV-1 in a high-burden African setting: implications for TB control Source: Eur Respir J, 50 (1) 1700004; 10.1183/13993003.00004-2017 Year: 2017
Universal HIV testing in London tuberculosis clinics: a cluster randomised controlled trial Source: Eur Respir J 2013; 41: 627-634 Year: 2013
HIV screening in tuberculosis patients, in the northern region of Portugal Source: International Congress 2015 – Screening strategies in TB Year: 2015
Tuberculosis (TB) detection with HIV infected patients Source: Annual Congress 2009 - Tuberculosis and HIV co-infection Year: 2009
Tuberculosis and HIV co-infection in European Union and European Economic Area countries Source: Eur Respir J 2011; 38: 1382-1392 Year: 2011
Treatment outcome among HIV positive and HIV negative TB patients in Chandigarh, India: A retrospective cohort study Source: International Congress 2015 – Management of TB: a patient focus Year: 2015
Treatment outcomes of MDR-TB and HIV co-infection in Europe Source: Eur Respir J, 49 (6) 1602363; 10.1183/13993003.02363-2016 Year: 2017
Diagnostics for latent TB infection: incremental, not transformative progress Source: Eur Respir J 2016; 47: 704-706 Year: 2016
Tuberculosis screening of migrants to low-burden nations: insights from evaluation of UK practice Source: Eur Respir J 2011; 37: 1175-1182 Year: 2011
Screening migrants for tuberculosis and latent TB infection: the reward will come later Source: Eur Respir J, 54 (4) 1901719; 10.1183/13993003.01719-2019 Year: 2019
The treatment of tuberculosis and application of HAART (highly active anti retroviral treatment) in HIV positive patients Source: Annual Congress 2005 - Challenges in the management of pulmonary tuberculosis: a continuous clinical problem Year: 2005
The twin epidemics: HIV / DR-TB co-infection in 2012 Source: International Congress 2015 – Epidemiology of TB: deaths, co-morbidities, migration and children Year: 2015
Safety of two step tuberculin skin test (TST) in the screening of healthcare workers for latent TB infection (LTBI) Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment Year: 2013
Implementation of lung cancer screening in Europe: the way forward Source: Virtual Congress 2020 – Thoracic oncology Year: 2020